Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients

Table 1 Clinical characteristics of the 189 patients included in the study

Tumor stage	Before NAC				After NAC
	T0	T1	T2	T3	T0	T1	T2	T3
	0	19	131	39	30	61	69	29
Histopathology	Ductal		Lobular				Others
	179		3				7
Involvement of lymph nodes	Before NAC				After NAC
	Yes		No		Yes		No
	129		60		112		77
Type of NAC	Cytotoxic		Cytotoxic + trastuzumab or Cytotoxic + trastuzumab + patozumab
	163		26

Biomarkers of core-needle biopsies and surgical specimens are referred as before NAC and after NAC, respectively

ISSN: 1746-1596